The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh

被引:34
|
作者
Al Kibria, Gulam Muhammed [1 ]
Swasey, Krystal [1 ]
Choudhury, Allysha [2 ]
Burrowes, Vanessa [2 ]
Stafford, Kristen A. [1 ]
Uddin, S. M. Iftekhar [3 ]
Mirbolouk, Mohammadhassan [3 ]
Sharmeen, Atia [4 ]
Angela, K. C. [2 ]
Mitra, Dipak K. [5 ]
机构
[1] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21205 USA
[4] Morgan State Univ, Sch Community Hlth & Policy, Baltimore, MD 21251 USA
[5] North South Univ, Dept Publ Hlth, Dhaka 1229, Bangladesh
基金
英国医学研究理事会;
关键词
BLOOD-PRESSURE; MORTALITY;
D O I
10.1038/s41371-018-0080-z
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We analyzed the Bangladesh Demographic and Health Survey 2011 data to examine absolute differences in hypertension prevalence according to the hypertension definition of the "2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" and "Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7)" 2003 guidelines. Among 7839 participants >= 35 years, the JNC7 and 2017 ACC/AHA classified 25.7% (95% confidence interval (CI): 24.5-27.0%) and 48.0% (95% CI: 46.4-49.7%) people hypertensive, respectively. The JNC7 prevalence was 19.4% (95% CI: 18.0-21.0%) among males and 31.9% (95% CI: 30.1-33.6%) among females. The prevalence was 41.4% (95% CI: 39.4-43.5%) among males and 54.5% (95% CI: 52.4-56.4%) among females as per the 2017 ACC/AHA guideline. From JNC7 to 2017 ACC/AHA, the overall difference in prevalence was 22.3% (95% CI: 19.8-24.8%). Males and females had similar differences, 22.0% (95% CI: 18.3-25.7%) and 22.6% (95% CI: 19.4-26.0%), respectively. As per the 2017 ACC/AHA guideline, >50% prevalence was observed among people with body mass index >= 25kg/m(2), college-level education, co-morbid diabetes, richest wealth quintile, females, age >= 55 years, urban residence, or living in Khulna, Rangpur or Dhaka divisions; the absolute difference was >20% in most categories. We found a substantial increase in the prevalence of hypertension due to change in blood pressure thresholds as per the 2017 ACC/AHA guideline. We recommend conducting more comprehensive population-based studies to estimate the recent burden of hypertension in Bangladesh. Future studies should estimate similar prevalence in other countries.
引用
收藏
页码:608 / 616
页数:9
相关论文
共 50 条
  • [31] Stage 1 hypertension defined by the 2017 ACC/AHA blood pressure guideline and cardiometabolic multimorbidity in Chinese adults
    Qin, Xiaoru
    Chen, Chaolei
    Wang, Jiabin
    Nie, Zhiqiang
    Ou, Yanqiu
    Jiang, Xiaofei
    Feng, Yingqing
    JOURNAL OF CLINICAL HYPERTENSION, 2023, 25 (10): : 943 - 950
  • [32] Association of stage 1 hypertension defined by the 2017 ACC/AHA guideline with cardiovascular events and mortality in Chinese adults
    Gao Qiannan
    Li Liuxin
    Bai Jingjing
    Fan Luyun
    Tan Jiangshan
    Wu Shouling
    Cai Jun
    中华医学杂志英文版, 2024, 137 (01)
  • [33] Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey
    Gupta, Kartik
    Ramakrishnan, Sivasubramanian
    Zachariah, Geevar
    Rao, J. Shivkumar
    Mohanan, P. P.
    Venugopal, K.
    Sateesh, Santosh
    Sethi, Rishi
    Jain, Dharmendra
    Bardolei, Neil
    Mani, Kalaivani
    Kakar, Tanya Singh
    Jain, Vardhmaan
    Gupta, Prakash
    Gupta, Rajeev
    Bansal, Sandeep
    Nath, Ranjit K.
    Tyagi, Sanjay
    Wander, G. S.
    Gupta, Satish
    Mandal, Subroto
    Senguttuvan, Nagendra Boopathy
    Subramanyam, Geetha
    Roy, Debabatra
    Datta, Sibananda
    Ganguly, Kajal
    Routray, S. N.
    Mishra, S. S.
    Singh, B. P.
    Bharti, B. B.
    Das, Mrinal Kanti
    Deb, P. K.
    Deedwania, Prakash
    Seth, Ashok
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 7
  • [34] New 2017 ACC/AHA Hypertension Guidelines-Cost-Effectiveness among US Adults with Type 2 Diabetes
    Shao, Hui
    Laxy, Michael
    Rolka, Deborah B.
    Gregg, Edward W.
    Zhang, Ping
    DIABETES, 2018, 67
  • [35] Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline
    Dorans, Kirsten S.
    Mills, Katherine T.
    Liu, Yang
    He, Jiang
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (11):
  • [36] Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline
    Zhou, Yaqing
    Jia, Limei
    Lu, Baojin
    Gu, Guoqiang
    Hu, Haijuan
    Zhang, Ziyuan
    Bai, Long
    Cui, Wei
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (06): : 758 - 765
  • [37] Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China
    Zhao, Bin
    Li, Jing
    Liu, Jie
    Hao, Yuming
    Zhen, Yanjie
    Feng, Di
    Xu, Menghui
    Chen, Ximin
    Yang, Xiulan
    Zuo, Aifang
    Jia, Rufu
    Zhang, Ruiqin
    Fan, Ailing
    Wang, Yun
    Yuan, Meijin
    Tong, Li
    Chen, Shuling
    Cui, Jing
    Zhao, Meizhu
    Cui, Wei
    BMJ OPEN, 2019, 9 (08):
  • [38] ACC/AHA Hypertension Guideline: What Is New? What Do We Do?
    LeFevre, Michael
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (06) : 372 - 373
  • [39] Prevalence and Trends of Isolated Systolic Hypertension among Untreated Older People in the US according to the 2017 ACC/AHA Guideline, 2001-16
    Al Kibria, Gulam Muhammed
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (01) : 101 - 103
  • [40] Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline
    Li, Dan
    Zeng, Xiaofang
    Huang, Yi
    Lei, Han
    Li, Ge
    Zhang, Nan
    Huang, Wei
    CURRENT HYPERTENSION REPORTS, 2019, 21 (03)